UnitedHealth Group Q3 2026 Earnings Call Transcript
Key takeaways
- UnitedHealth’s Q3 2026 results and guidance reinforce a strong growth trajectory, with AI and Medicare initiatives driving future earnings.
- Revenue Q3 2026: $113 billion
- Adjusted EPS Q3 2026: $4.69
- Full‑year 2026 adjusted EPS guidance: ≥$20.50
What happened
UnitedHealth Group (UNH) reported third‑quarter 2026 revenue of $113 billion and adjusted earnings per share of $4.69, up from $2.92 a year earlier. The company raised its full‑year 2026 adjusted EPS guidance to at least $20.50 and reiterated a long‑term growth target of 13%–16%. It highlighted AI‑enabled efficiencies, Medicare Advantage performance, and a 75% share of members in four‑plus‑star plans by 2027.
Why it matters
The earnings beat signals strong operational execution across UnitedHealthcare and Optum, supporting the company’s high‑growth outlook. The updated EPS guidance confirms a solid run‑rate and underlines confidence in 2027 and beyond, potentially lifting investor expectations. AI and value‑based care initiatives…
Short-term and longer-term
Short-term. Short‑term traders should watch the earnings release for any upside or downside surprises that could trigger a 2–3% move in UNH.
Longer-term. Over the next 12–18 months, UnitedHealth’s focus on AI modernization, Medicare Advantage expansion, and a 75% share of high‑star plans positions it to capture sustainable margin growth.